1 Min Read
LONDON, June 3 (Reuters) - AstraZeneca
* Novel antibiotic candidate azd0914 given fast track status by us fda Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.